NCT04903197 2026-04-01Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin LymphomaNovartisPhase 1 Terminated18 enrolled
NCT03547115 2026-03-17A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLMEI Pharma, Inc.Phase 1 Terminated84 enrolled
NCT06256484 2026-03-11A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaAtara BiotherapeuticsPhase 1 Terminated1 enrolled